tiprankstipranks
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
US Market
EMMA
Emmaus Life Sciences
RESEARCH TOOLSreports

Emmaus Life Sciences (EMMA) Financial Statements

88 Followers

Emmaus Life Sciences Financial Overview

Emmaus Life Sciences's market cap is currently $701.88K. The company's EPS TTM is $-0.03; its P/E ratio is -0.11; Emmaus Life Sciences is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Jun 24Dec 22Mar 22
Income Statement
Total Revenue$ 12.45M$ 16.65M$ 29.60M$ 18.39M$ 20.61M
Gross Profit$ 11.60M$ 15.45M$ 28.25M$ 15.80M$ 17.30M
Operating Income$ 231.00K$ -1.89M$ 3.54M$ -6.59M$ -6.13M
EBITDA$ -310.00K$ -910.00K$ 3.62M$ -5.50M$ -12.76M
Net Income$ -7.49M$ -6.45M$ -3.73M$ -10.63M$ -15.95M
Balance Sheet
Cash & Short-Term Investments$ 2.13M$ 1.39M$ 2.55M$ 2.02M$ 2.28M
Total Assets$ 21.44M$ 23.60M$ 35.18M$ 48.23M$ 56.73M
Total Debt$ 32.56M$ 32.96M$ 32.65M$ 30.82M$ 29.91M
Net Debt$ 30.43M$ 31.57M$ 30.10M$ 28.80M$ 27.64M
Total Liabilities$ 85.04M$ 80.08M$ 82.94M$ 82.32M$ 78.18M
Stockholders' Equity$ -63.61M$ -56.48M$ -47.76M$ -34.09M$ -21.45M
Cash Flow
Free Cash Flow$ -12.00K$ -2.30M$ -1.52M$ -5.10M$ -1.33M
Operating Cash Flow$ -11.00K$ -2.29M$ -1.50M$ -5.07M$ -1.25M
Investing Cash Flow$ 2.17M$ 2.50M$ -432.00K$ -2.39M$ -6.38M
Financing Cash Flow$ -1.43M$ -1.35M$ 2.48M$ 7.23M$ 7.41M
Currency in USD

Emmaus Life Sciences Earnings and Revenue History

Income Statement >

Emmaus Life Sciences Debt to Assets

Balance Sheet >

Emmaus Life Sciences Cash Flow

Cash Flow >

Emmaus Life Sciences Forecast EPS vs Actual EPS

Earnings >